News
Health
- Update Date：2023-03-25
- Units：Health Center
There have been cases of Mpox reported in Taiwan.
Modes of transmission:
(1) Person-to-person: Contact with respiratory secretions, damaged skin, mucous membranes, or contaminated objects of an infected individual. Mpox can be transmitted through close contact, such as through intimate sexual contact. Sexual contact is the main mode of transmission in this outbreak.
(2) Zoonotic transmission: Direct contact with infected animal blood, bodily fluids, damaged skin, or mucous membranes. Consumption of infected animal meat.
The incubation period is approximately between 3 and 21 days.
Preventive measures for Mpox include:
(1) Reducing interpersonal transmission risk: Mpox primarily spreads through close contact. It is important to avoid direct skin contact, kissing, hugging, and sexual activity with Mpox patients. Maintaining good hand hygiene is crucial.
(2) Reducing zoonotic transmission risk: When visiting areas where Mpox virus is prevalent, avoid contact with rodents, primates, and sick or dead animals. All food must be thoroughly cooked before consumption.
Recommended recipients for Mpox vaccination are as follows:
PrEP:
(1) Laboratory personnel working with orthopoxviruses.
(2) High-risk contacts who have had any form of sexual contact with confirmed Mpox cases but have not received post-exposure prophylaxis (PEP) vaccination.
(3) Individuals engaged in high-risk behaviors within the past year, such as having multiple sexual partners, engaging in sex work, or having sex in commercial establishments. Individuals with a history of sexually transmitted infections or engaging in sexual activity with partners meeting any of the aforementioned criteria.
(4) Healthcare and sanitation personnel involved in caring for confirmed Mpox cases, assisting with specimen collection from suspected cases, or administering Mpox vaccination.
PEP:(PEP should be administered within four days of the last contact.)
(1) Household members.
(2) Individuals who have had any form of sexual contact with a suspected Mpox case.
(3) Healthcare personnel who were in the same room as the case or within 2 meters during aerosol-generating medical procedures without wearing N95 masks and goggles/face shields. (4) Individuals involved in cleaning contaminated rooms without appropriate protection, potentially exposing them to inhalation of droplets or airborne particles.
(5) Individuals involved in laboratory procedures who were exposed to live Mypox virus under conditions without appropriate protection or who handled samples potentially containing the virus.
If you have suspected symptoms such as fever, chills/shivering, headache, muscle pain, back pain, joint pain, swollen lymph nodes (around the ears, armpits, neck, or groin) and any skin lesions, such as rashes, blisters, macules, maculopapular rashes, pustules, etc.
You should wear a mask and seek medical treatment as soon as possible and inform your doctor about your travel history and contact tracing.
Stay safe and take care.
(1) Person-to-person: Contact with respiratory secretions, damaged skin, mucous membranes, or contaminated objects of an infected individual. Mpox can be transmitted through close contact, such as through intimate sexual contact. Sexual contact is the main mode of transmission in this outbreak.
(2) Zoonotic transmission: Direct contact with infected animal blood, bodily fluids, damaged skin, or mucous membranes. Consumption of infected animal meat.
The incubation period is approximately between 3 and 21 days.
Preventive measures for Mpox include:
(1) Reducing interpersonal transmission risk: Mpox primarily spreads through close contact. It is important to avoid direct skin contact, kissing, hugging, and sexual activity with Mpox patients. Maintaining good hand hygiene is crucial.
(2) Reducing zoonotic transmission risk: When visiting areas where Mpox virus is prevalent, avoid contact with rodents, primates, and sick or dead animals. All food must be thoroughly cooked before consumption.
Recommended recipients for Mpox vaccination are as follows:
PrEP:
(1) Laboratory personnel working with orthopoxviruses.
(2) High-risk contacts who have had any form of sexual contact with confirmed Mpox cases but have not received post-exposure prophylaxis (PEP) vaccination.
(3) Individuals engaged in high-risk behaviors within the past year, such as having multiple sexual partners, engaging in sex work, or having sex in commercial establishments. Individuals with a history of sexually transmitted infections or engaging in sexual activity with partners meeting any of the aforementioned criteria.
(4) Healthcare and sanitation personnel involved in caring for confirmed Mpox cases, assisting with specimen collection from suspected cases, or administering Mpox vaccination.
PEP:(PEP should be administered within four days of the last contact.)
(1) Household members.
(2) Individuals who have had any form of sexual contact with a suspected Mpox case.
(3) Healthcare personnel who were in the same room as the case or within 2 meters during aerosol-generating medical procedures without wearing N95 masks and goggles/face shields. (4) Individuals involved in cleaning contaminated rooms without appropriate protection, potentially exposing them to inhalation of droplets or airborne particles.
(5) Individuals involved in laboratory procedures who were exposed to live Mypox virus under conditions without appropriate protection or who handled samples potentially containing the virus.
If you have suspected symptoms such as fever, chills/shivering, headache, muscle pain, back pain, joint pain, swollen lymph nodes (around the ears, armpits, neck, or groin) and any skin lesions, such as rashes, blisters, macules, maculopapular rashes, pustules, etc.
You should wear a mask and seek medical treatment as soon as possible and inform your doctor about your travel history and contact tracing.
Stay safe and take care.
Related Image(s)：
